Skip to content
Psilocybin Alpha is becoming Psychedelic Alpha - Please bear with us.
  • Insights

      Weekly Bulletin

      Your weekly recap of news and analysis from the psychedelic sector.

      Read the Latest

      Research Review

      A monthly review of the most important psychedelics research.

      Review Archive

      News & Interviews

      The latest news from across the psychedelics space.

      Explore Now
  • Data

      Psychedelics Patent Trackers

      We track the latest patents and filings related to psilocybin, MDMA and DMT.

      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents
      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents

      Psychedelic Legalization & Decriminalization Tracker

      Mapping psychedelic drug policy reform across the United States

      Explore the Tracker

      Psychedelics Drug Development Tracker

      From drug discovery to regulatory approval, we map drug development in psychedelics.

      Explore the Tracker
  • Companies

      Stocks & Companies Directory

      A directory of all the major psychedelics stocks, companies and ETFs.

      Access Directory

      Sector Landscape Map

      Explore the Psychedelic Sector Landscape visually using our new tool.

      Explore Now

      Stock Watchlist

      A one-stop overview of psychedelics stocks financial performance.

      Explore Now
  • Psychedelic Careers
  • Contact
Search
Close
Read more about the article Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonists Show Significant Reduction in Binge Eating

Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonists Show Significant Reduction in Binge Eating

  • Post published:March 3, 2021
  • Post category:Press Release
Read more about the article Bright Minds Biosciences Inc. Announces Pricing of Public Marketed Offering of Units

Bright Minds Biosciences Inc. Announces Pricing of Public Marketed Offering of Units

  • Post published:February 23, 2021
  • Post category:Press Release
Read more about the article Bright Minds Biosciences Inc. Announces Marketed Public Offering

Bright Minds Biosciences Inc. Announces Marketed Public Offering

  • Post published:February 22, 2021
  • Post category:Press Release
Read more about the article Bright Minds Biosciences Strengthens Scientific Advisory Team to Prepare for Future Growth

Bright Minds Biosciences Strengthens Scientific Advisory Team to Prepare for Future Growth

  • Post published:February 10, 2021
  • Post category:Press Release
Read more about the article Bright Minds Biosciences Announces Listing on Canadian Stock Exchange

Bright Minds Biosciences Announces Listing on Canadian Stock Exchange

  • Post published:February 5, 2021
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Psychedelic Stocks and Companies
  • News & Interviews
  • Psychedelic Sector Jobs
  • Data Bank

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

  • Psychedelic Alpha © 2022, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Join Our Newsletter

Psychedelic sector insights, interviews and analysis delivered to your inbox.

No thanks, continue to site.